Bristol-Myers Squibb, Cash, Cheniere Energy And This Tech Company Are CNBC''s Final Trades
On CNBC’s “ Halftime Report Final Trades ,” Jim Lebenthal of Cerity Partners said Bristol-Myers Squibb Co (NYSE: BMY ) has a “good dividend yield” and is a “cheap stock in a defensive industry.” “I think this is an easy one to buy no matter what you … Full story available on Benzinga.com
Bristol-Myers Squibb, Cash, Cheniere Energy And This Tech Company Are CNBC''s Final Trades
On CNBC’s “ Halftime Report Final Trades ,” Jim Lebenthal of Cerity Partners said Bristol-Myers Squibb Co (NYSE: BMY ) has a “good dividend yield” and is a “cheap stock in a defensive industry.” “I think this is an easy one to buy no matter what you … Full story available on Benzinga.com